Patients with systemic lupus erythematosus (SLE) often face many concerns, fears and uncertainties that render “treatment decision making very difficult,” says Jasvinder Singh, MD, MPH, professor of medicine and epidemiology at the University of Alabama at Birmingham. Often these patients, who tend to be women from minority groups, “do not have access to easily understandable…
Arwen Pieterse, PhD, and colleagues urge all physicians to allocate more meaningful time to collaborate in shared decision making with patients, without compromising access or productivity…
A group led by Sarah Ringold, MD, MS, assistant professor of rheumatology at Seattle Children’s Hospital, has developed a new guideline intended to provide recommendations for the treatment and monitoring of children with juvenile idiopathic arthritis (JIA) manifesting as non-systemic polyarthritis, sacroiliitis or enthesitis.1,2 Key Updates The new recommendations appear in both Arthritis & Rheumatology…
Over the past several decades, the medical community has been moving toward a model of shared decision making. In addition to its ethical advantages, shared decision making potentially yields such benefits as improved medical adherence and better health outcomes. With the proliferation of treatment options and changes in the larger culture, shared decision making is…
SAN DIEGO—At the ACR/ARHP 2017 Annual Meeting Nov. 3–8, a session on how to promote shared decision making with patients highlighted the role of the multidisciplinary professional team. And perhaps just as importantly, it noted the importance of providers recognizing their own implicit biases, which can get in the way of shared decision making. Presenters…
A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions
Engaging patients in shared decision-making about their health management is increasingly important to improving health outcomes and quality of life for persons with arthritis and other rheumatic diseases. In shared decision-making, the patient and the provider are partners who share information and determine together the best therapeutic interventions to achieve desired health outcomes and patient goals.
The treatment and management of rheumatoid arthritis (RA) is ever evolving. Here Clifton O. Bingham, MD, discusses the application of RA guidelines, the most recent drug safety information and more.
Experts presented ways to rethink journal club to improve engagement and how an image-based program can help teach the assessment of cutaneous lupus erythematosus across differing skin tones.
Patients who reviewed an industry-sponsored booklet about a commonly used rheumatoid arthritis drug were twice as likely to choose the proposed therapy as were patients who reviewed similar decision-aid material presented in a neutral manner, according to a recent study. Richard Martin, MD, MA, professor of medicine, rheumatology, at Michigan State University College of Human…